BR112016019588A2 - produto de ativação de mmp-8, e, método de determinação da ativação da mmp-8 em uma amostra - Google Patents

produto de ativação de mmp-8, e, método de determinação da ativação da mmp-8 em uma amostra

Info

Publication number
BR112016019588A2
BR112016019588A2 BR112016019588A BR112016019588A BR112016019588A2 BR 112016019588 A2 BR112016019588 A2 BR 112016019588A2 BR 112016019588 A BR112016019588 A BR 112016019588A BR 112016019588 A BR112016019588 A BR 112016019588A BR 112016019588 A2 BR112016019588 A2 BR 112016019588A2
Authority
BR
Brazil
Prior art keywords
mmp
activation
sample
product
activation product
Prior art date
Application number
BR112016019588A
Other languages
English (en)
Other versions
BR112016019588B1 (pt
Inventor
Korvuo Armi
Gieselmann Dirk-Rolf
Råman Ismo
Maier Kurt
Mäntylä Päivi
Tiisala Sinikka
Sorsa Timo
Original Assignee
Dentognostics Gmbh
Oy Medix Biochemica Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dentognostics Gmbh, Oy Medix Biochemica Ab filed Critical Dentognostics Gmbh
Publication of BR112016019588A2 publication Critical patent/BR112016019588A2/pt
Publication of BR112016019588B1 publication Critical patent/BR112016019588B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24034—Neutrophil collagenase (3.4.24.34)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/18—Dental and oral disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

a presente invenção refere-se a um produto de ativação de mmp-8 novo, como um produto de ativação da parte mediana da mmp-8. a invenção também se refere à detecção de tal produto de ativação de mmp-8 ou de fragmentos de mmp-8 ativados em uma amostra biológica derivada de um indivíduo, e ao uso do mesmo para diagnosticar doenças que se relacionam a níveis elevados ou anormais de mmp-8 ativada.
BR112016019588-4A 2014-02-27 2015-02-27 Método de determinação da ativação da mmp-8 em uma amostra BR112016019588B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20145192A FI127924B (en) 2014-02-27 2014-02-27 METHOD OF MEASURING MMP-8 ACTIVATION
FI20145192 2014-02-27
PCT/FI2015/050121 WO2015128549A1 (en) 2014-02-27 2015-02-27 Mmp-8 activation product, its determination and use

Publications (2)

Publication Number Publication Date
BR112016019588A2 true BR112016019588A2 (pt) 2017-10-24
BR112016019588B1 BR112016019588B1 (pt) 2023-11-14

Family

ID=54008229

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016019588-4A BR112016019588B1 (pt) 2014-02-27 2015-02-27 Método de determinação da ativação da mmp-8 em uma amostra

Country Status (9)

Country Link
US (2) US10488415B2 (pt)
EP (1) EP3110949A4 (pt)
JP (1) JP6613241B2 (pt)
KR (1) KR102265490B1 (pt)
CN (1) CN106232809A (pt)
BR (1) BR112016019588B1 (pt)
CA (1) CA2940588C (pt)
FI (1) FI127924B (pt)
WO (1) WO2015128549A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105223347B (zh) * 2015-09-22 2017-03-08 福州大学 一种半定量可视化酶联免疫分析方法
FI127416B (en) * 2016-09-29 2018-05-31 Oy Medix Biochemica Ab Cardiovascular risk assessment method
WO2020138965A1 (ko) * 2018-12-26 2020-07-02 주식회사 수젠텍 치주질환 진단 방법, 이를 위한 조성물 및 키트
CN109459568A (zh) * 2019-01-15 2019-03-12 西安交通大学 纸基牙周炎检测装置和牙周炎检测方法
KR102266531B1 (ko) * 2019-11-12 2021-06-21 아주대학교산학협력단 타액 단백질 마커를 이용한 잇몸 상태의 진단방법
CN111879940B (zh) * 2020-04-28 2022-02-01 中国科学院微生物研究所 肺结核标志物及应用
CN112649417B (zh) * 2020-12-01 2021-10-29 西北大学 一种检测mmp-14的电化学发光生物传感器及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
FI990888A0 (fi) 1999-04-20 1999-04-20 Medix Biochemica Ab Oy Menetelmä ja testikittejä respiratorisen alueen tulehduksen läsnäolon ja vaikeusasteen arvioimiseksi
US6869951B1 (en) 1999-07-16 2005-03-22 Pharmacia Corporation Method of changing conformation of a matrix metalloproteinase
WO2002003994A1 (en) * 2000-07-12 2002-01-17 G.D. Searle & Co. N sulfonyl aminoacid derivatives as inhibitors of metalloproteinase
JP4314128B2 (ja) * 2004-02-24 2009-08-12 株式会社インシリコサイエンス タンパク質立体構造と誘導適合を利用したリガンド探索方法
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US8568996B2 (en) * 2008-10-21 2013-10-29 University of Pittsburgh—of the Commonwealth System of Higher Education MMP activation peptide detection in biological samples
JP5649589B2 (ja) * 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド マトリックスメタロプロテアーゼ１の温度感受性突然変異体およびその使用
CA2878094A1 (en) 2012-06-27 2014-01-03 Siscapa Assay Technologies, Inc. Multipurpose mass spectrometric assay panels for peptides

Also Published As

Publication number Publication date
EP3110949A4 (en) 2017-10-18
FI127924B (en) 2019-05-31
US20170023571A1 (en) 2017-01-26
JP6613241B2 (ja) 2019-11-27
US20200064346A1 (en) 2020-02-27
CA2940588C (en) 2023-08-22
EP3110949A1 (en) 2017-01-04
KR102265490B1 (ko) 2021-06-18
CN106232809A (zh) 2016-12-14
CA2940588A1 (en) 2015-09-03
BR112016019588B1 (pt) 2023-11-14
US11378579B2 (en) 2022-07-05
WO2015128549A1 (en) 2015-09-03
US10488415B2 (en) 2019-11-26
KR20160146668A (ko) 2016-12-21
JP2017507659A (ja) 2017-03-23

Similar Documents

Publication Publication Date Title
BR112016019588A2 (pt) produto de ativação de mmp-8, e, método de determinação da ativação da mmp-8 em uma amostra
BR112017017286A2 (pt) protease de cisteína
BR112017012704A2 (pt) imunomoduladores
BR112017017284A2 (pt) protease de cisteína
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
CL2018000596A1 (es) Nuevos compuestos bicíclicos como inhibidores de la atx
BR112017007379A2 (pt) moléculas de anticorpo para pd-l1 e usos das mesmas
BR112017003718A2 (pt) inibidores macrocíclicos das interações de proteína/proteína de pd-1/pd-l1 e cd80(b7-1)/pd-l1
AU2015286723B2 (en) Influenza virus vaccines and uses thereof
BR112016025627A2 (pt) biomarcadores e combinações dos mesmos para diagnóstico de tuberculose
EP3347695A4 (en) ANALYZE INSTRUMENT, APPROPRIATE SYSTEMS AND METHOD
BR112018003019A2 (pt) vacinas terapêuticas contra hpv18
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
GB2547567A (en) Contractile function measuring devices, systems, and methods of use thereof
EP3523639A4 (en) DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR DIAGNOSTIC MULTIANALYTE TEST ELEMENTS AND METHOD FOR USE THEREOF
BR112017004056A2 (pt) composições e métodos para detecção da proteína smn em um indivíduo e tratamento de um indivíduo
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
MX2017008096A (es) Pestivirus.
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
EP3693742A3 (en) Methods of detecting prostate cancer
BR112016022214A2 (pt) rnase para uso no tratamento ou prevenção de infecções virais
MX2022010954A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
BR112015004629A2 (pt) polipeptídeos de clostridium difficile como vacinas
BR112017021850A2 (pt) detecção de isoformas específicas de clusterina
BR112016024622A2 (pt) composições e métodos para melhorar e/ou prever a amplificação de dna

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: DENTOGNOSTICS GMBH (DE) ; OY MEDIX BIOCHEMICA AB (FI)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/02/2015, OBSERVADAS AS CONDICOES LEGAIS